Advertisement
Screener

XERIS BIOPHARMA HOLDINGS, INC. (XERS) Customer Breakdown

XERIS BIOPHARMA HOLDINGS, INC. Customer Breakdown

Customer relationships and concentrations across all retained periods. Named customers and their revenue are shown when disclosed. Anonymous customers, customer groups and sales channels are labelled separately. Receivable concentration measures unpaid balances, not revenue contribution. A biggest customer by revenue can be identified only from disclosed customer revenue. Missing names and amounts remain missing; identities are not assumed to match between periods.

Period / as ofCustomer / groupCategoryCustomer revenueShare of revenueShare of trade receivablesBasis and limitations

Similar stocks

Stock NameCountryMarket CapPE Ratio
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Innoviva, Inc. (INVA)United States$1.493B4.62
Xencor Inc (XNCR)United States$1.776B-7.33
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Septerna, Inc. (SEPN)United States$1.783B-63.01